Interaction Propensity
Strongest directed Tier 1 cell-ontology contact preference per sample. Bulk files are centralized on the Download page.
151-200 of 2,070
Interaction Propensity
Strongest directed Tier 1 cell-ontology contact preference per sample.
2,069 ready
| Sample | Organ | Disease state | Cells | Strongest directed pair ?Tier 1 from-label to to-label pair with the largest departure from neutral propensity among enriched/depleted contacts. | Direction | Propensity | FDR |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_B2,1 | Lung | Primary cancer | 2,353 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.01 | 1.32e-2 |
| NSCLC_38242124__IMC__175_B2,10 | Lung | Primary cancer | 2,177 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.08 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B2,11 | Lung | Primary cancer | 3,015 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.21 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B2,12 | Lung | Primary cancer | 2,539 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.47 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B2,13 | Lung | Primary cancer | 3,504 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.67 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B2,14 | Lung | Primary cancer | 2,748 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.56 | 1.58e-2 |
| NSCLC_38242124__IMC__175_B2,15 | Lung | Primary cancer | 3,020 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.98 | 1.32e-2 |
| NSCLC_38242124__IMC__175_B2,16 | Lung | Primary cancer | 3,084 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.97 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B2,17 | Lung | Primary cancer | 2,285 | Stromal -> Stromal | Enriched | 3.91 | 1.44e-2 |
| NSCLC_38242124__IMC__175_B2,2 | Lung | Primary cancer | 1,910 | Immune -> Stromal | Enriched | 4.38 | 2.26e-2 |
| NSCLC_38242124__IMC__175_B2,3 | Lung | Primary cancer | 4,979 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.48 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B2,4 | Lung | Primary cancer | 3,269 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.29 | 1.76e-2 |
| NSCLC_38242124__IMC__175_B2,5 | Lung | Primary cancer | 3,929 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.43 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B2,6 | Lung | Primary cancer | 3,446 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.36 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B2,7 | Lung | Primary cancer | 3,595 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.69 | 2.26e-2 |
| NSCLC_38242124__IMC__175_B2,8 | Lung | Primary cancer | 2,386 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.03 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B2,9 | Lung | Primary cancer | 4,016 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.04 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B3,1 | Lung | Primary cancer | 3,874 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.08 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B3,10 | Lung | Primary cancer | 1,896 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.19 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B3,11 | Lung | Primary cancer | 2,889 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.35 | 2.26e-2 |
| NSCLC_38242124__IMC__175_B3,12 | Lung | Primary cancer | 4,330 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.56 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B3,13 | Lung | Primary cancer | 912 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.05 | 1.98e-2 |
| NSCLC_38242124__IMC__175_B3,15 | Lung | Primary cancer | 2,727 | Stromal -> Stromal | Enriched | 3.38 | 1.58e-2 |
| NSCLC_38242124__IMC__175_B3,16 | Lung | Primary cancer | 4,456 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.25 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B3,17 | Lung | Primary cancer | 2,318 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.30 | 1.44e-2 |
| NSCLC_38242124__IMC__175_B3,2 | Lung | Primary cancer | 3,084 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.66 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B3,3 | Lung | Primary cancer | 4,329 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.51 | 1.58e-2 |
| NSCLC_38242124__IMC__175_B3,4 | Lung | Primary cancer | 1,576 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.70 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B3,5 | Lung | Primary cancer | 3,081 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.52 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B3,6 | Lung | Primary cancer | 3,664 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.24 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B3,7 | Lung | Primary cancer | 2,763 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.71 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B3,8 | Lung | Primary cancer | 4,496 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.94 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B3,9 | Lung | Primary cancer | 3,044 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.53 | 1.44e-2 |
| NSCLC_38242124__IMC__175_B4,1 | Lung | Primary cancer | 3,046 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.99 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B4,10 | Lung | Primary cancer | 1,320 | Immune -> Immune | Enriched | 3.56 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B4,11 | Lung | Primary cancer | 2,898 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.43 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B4,12 | Lung | Primary cancer | 4,536 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.76 | 1.58e-2 |
| NSCLC_38242124__IMC__175_B4,13 | Lung | Primary cancer | 2,834 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.62 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B4,14 | Lung | Primary cancer | 3,599 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.05 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B4,15 | Lung | Primary cancer | 3,084 | Stromal -> Stromal | Enriched | 3.84 | 1.76e-2 |
| NSCLC_38242124__IMC__175_B4,16 | Lung | Primary cancer | 4,218 | Immune -> Immune | Enriched | 4.19 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B4,17 | Lung | Primary cancer | 3,092 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.31 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B4,2 | Lung | Primary cancer | 2,911 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.31 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B4,3 | Lung | Primary cancer | 3,892 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.11 | 1.76e-2 |
| NSCLC_38242124__IMC__175_B4,4 | Lung | Primary cancer | 2,855 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.71 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B4,5 | Lung | Primary cancer | 3,190 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.01 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B4,6 | Lung | Primary cancer | 3,026 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.85 | 9.90e-3 |
| NSCLC_38242124__IMC__175_B4,7 | Lung | Primary cancer | 2,360 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.63 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B4,8 | Lung | Primary cancer | 5,430 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.99 | 1.06e-2 |
| NSCLC_38242124__IMC__175_B4,9 | Lung | Primary cancer | 3,378 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.66 | 1.76e-2 |